Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT01086020
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Registry
-
NCT01086020
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01086020. Randomized; no masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Atorvastatin Plus Ezetimibe on Coronary Plaque Progression
- Acronym
- AEPP
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- atorvastatin
- Intervention (Drug)
- atorvastatin plus ezetimibe
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct01086020- Content hash
62a44d19a2f7849d951446ee94f5826b0987a0a56df12247e63d8bbec5bac83e